Literature DB >> 30003339

Isosteres of hydroxypyridinethione as drug-like pharmacophores for metalloenzyme inhibition.

Rebecca N Adamek1, Cy V Credille1, Benjamin L Dick1, Seth M Cohen2.   

Abstract

Hydroxypyridinethiones (pan class="Chemical">HOPTOs) are strong ligands for metal ions and potentially useful pharmacophores for inhibiting metalloenzymes relevant to human disease. However, HOPTOs have been sparingly used in drug discovery efforts due, in part, to concerns that this scaffold will act as a promiscuous, non-selective metalloenzyme inhibitor, as well as possess poor pharmacokinetics (PK), which may undermine drug candidates containing this functional group. To advance HOPTOs as a useful pharmacophore for metalloenzyme inhibitors, a library of 22 HOPTO isostere compounds has been synthesized and investigated. This library demonstrates that it is possible to maintain the core metal-binding pharmacophore (MBP) while generating diversity in structure, electronics, and PK properties. This HOPTO library has been screened against a set of four different metalloenzymes, demonstrating that while the same metal-binding donor atoms are maintained, there is a wide range of activity between metalloenzyme targets. Overall, this work shows that HOPTO isosteres are useful MBPs and valuable scaffolds for metalloenzyme inhibitors.

Entities:  

Keywords:  Fragment-based drug discovery; Hydroxypyridinethione; Inhibitor; Isostere; Metal-binding pharmacophore; Metalloenzyme

Mesh:

Substances:

Year:  2018        PMID: 30003339      PMCID: PMC6330162          DOI: 10.1007/s00775-018-1593-1

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  43 in total

1.  A 'rule of three' for fragment-based lead discovery?

Authors:  Miles Congreve; Robin Carr; Chris Murray; Harren Jhoti
Journal:  Drug Discov Today       Date:  2003-10-01       Impact factor: 7.851

2.  Physiochemical drug properties associated with in vivo toxicological outcomes.

Authors:  Jason D Hughes; Julian Blagg; David A Price; Simon Bailey; Gary A Decrescenzo; Rajesh V Devraj; Edmund Ellsworth; Yvette M Fobian; Michael E Gibbs; Richard W Gilles; Nigel Greene; Enoch Huang; Teresa Krieger-Burke; Jens Loesel; Travis Wager; Larry Whiteley; Yao Zhang
Journal:  Bioorg Med Chem Lett       Date:  2008-07-24       Impact factor: 2.823

3.  A phase I and pharmacological study of the farnesyl protein transferase inhibitor L-778,123 in patients with solid malignancies.

Authors:  C D Britten; E K Rowinsky; S Soignet; A Patnaik; S L Yao; P Deutsch; Y Lee; R B Lobell; K E Mazina; H McCreery; S Pezzuli; D Spriggs
Journal:  Clin Cancer Res       Date:  2001-12       Impact factor: 12.531

4.  Chemistry: Chemical con artists foil drug discovery.

Authors:  Jonathan Baell; Michael A Walters
Journal:  Nature       Date:  2014-09-25       Impact factor: 49.962

Review 5.  Farnesyltransferase and geranylgeranyltransferase I inhibitors and cancer therapy: lessons from mechanism and bench-to-bedside translational studies.

Authors:  S M Sebti; A D Hamilton
Journal:  Oncogene       Date:  2000-12-27       Impact factor: 9.867

6.  New beginnings for matrix metalloproteinase inhibitors: identification of high-affinity zinc-binding groups.

Authors:  David T Puerta; Jana A Lewis; Seth M Cohen
Journal:  J Am Chem Soc       Date:  2004-07-14       Impact factor: 15.419

7.  Metal ions in biological catalysis: from enzyme databases to general principles.

Authors:  Claudia Andreini; Ivano Bertini; Gabriele Cavallaro; Gemma L Holliday; Janet M Thornton
Journal:  J Biol Inorg Chem       Date:  2008-07-05       Impact factor: 3.358

8.  Crystal structure of an avian influenza polymerase PA(N) reveals an endonuclease active site.

Authors:  Puwei Yuan; Mark Bartlam; Zhiyong Lou; Shoudeng Chen; Jie Zhou; Xiaojing He; Zongyang Lv; Ruowen Ge; Xuemei Li; Tao Deng; Ervin Fodor; Zihe Rao; Yingfang Liu
Journal:  Nature       Date:  2009-02-04       Impact factor: 49.962

Review 9.  An overview of FDA-approved new molecular entities: 1827-2013.

Authors:  Michael S Kinch; Austin Haynesworth; Sarah L Kinch; Denton Hoyer
Journal:  Drug Discov Today       Date:  2014-03-26       Impact factor: 8.369

10.  Structure Property Relationships of Carboxylic Acid Isosteres.

Authors:  Pierrik Lassalas; Bryant Gay; Caroline Lasfargeas; Michael J James; Van Tran; Krishna G Vijayendran; Kurt R Brunden; Marisa C Kozlowski; Craig J Thomas; Amos B Smith; Donna M Huryn; Carlo Ballatore
Journal:  J Med Chem       Date:  2016-03-30       Impact factor: 7.446

View more
  7 in total

1.  Alison Butler: papers in celebration of her 2018 ACS Alfred Bader Award in Bioorganic or Bioinorganic Chemistry.

Authors:  Lawrence Que
Journal:  J Biol Inorg Chem       Date:  2021-05       Impact factor: 3.358

2.  Investigation of Dipicolinic Acid Isosteres for the Inhibition of Metallo-β-Lactamases.

Authors:  Allie Y Chen; Pei W Thomas; Zishuo Cheng; Nasa Y Xu; David L Tierney; Michael W Crowder; Walter Fast; Seth M Cohen
Journal:  ChemMedChem       Date:  2019-05-24       Impact factor: 3.466

3.  Dual-Pharmacophore Pyrithione-Containing Cephalosporins Kill Both Replicating and Nonreplicating Mycobacterium tuberculosis.

Authors:  Landys Lopez Quezada; Kelin Li; Stacey L McDonald; Quyen Nguyen; Andrew J Perkowski; Cameron W Pharr; Ben Gold; Julia Roberts; Kathrine McAulay; Kohta Saito; Selin Somersan Karakaya; Prisca Elis Javidnia; Esther Porras de Francisco; Manuel Marin Amieva; Sara Palomo Dı Az; Alfonso Mendoza Losana; Matthew Zimmerman; Hsin-Pin Ho Liang; Jun Zhang; Veronique Dartois; Stéphanie Sans; Sophie Lagrange; Laurent Goullieux; Christine Roubert; Carl Nathan; Jeffrey Aubé
Journal:  ACS Infect Dis       Date:  2019-06-11       Impact factor: 5.084

4.  A Cephalosporin Prochelator Inhibits New Delhi Metallo-β-lactamase 1 without Removing Zinc.

Authors:  Abigail C Jackson; Jacqueline M Zaengle-Barone; Elena A Puccio; Katherine J Franz
Journal:  ACS Infect Dis       Date:  2020-04-29       Impact factor: 5.084

5.  Identification of Adenosine Deaminase Inhibitors by Metal-binding Pharmacophore Screening.

Authors:  Rebecca N Adamek; Paul Ludford; Stephanie M Duggan; Yitzhak Tor; Seth M Cohen
Journal:  ChemMedChem       Date:  2020-10-14       Impact factor: 3.466

6.  Hydroxypyridinethione Inhibitors of Human Insulin-Degrading Enzyme.

Authors:  Rebecca N Adamek; Caitlin N Suire; Ryjul W Stokes; Monica K Brizuela; Seth M Cohen; Malcolm A Leissring
Journal:  ChemMedChem       Date:  2021-03-31       Impact factor: 3.466

7.  Structural Isomerism and Enhanced Lipophilicity of Pyrithione Ligands of Organoruthenium(II) Complexes Increase Inhibition on AChE and BuChE.

Authors:  Jerneja Kladnik; Samuel Ristovski; Jakob Kljun; Andrea Defant; Ines Mancini; Kristina Sepčić; Iztok Turel
Journal:  Int J Mol Sci       Date:  2020-08-06       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.